People: Ligand Pharmaceuticals Inc (LGND.O)

LGND.O on Consolidated Issue listed on NASDAQ Global Market

52.96USD
26 Dec 2014
Price Change (% chg)

$1.17 (+2.26%)
Prev Close
$51.79
Open
$52.18
Day's High
$53.69
Day's Low
$52.18
Volume
129,873
Avg. Vol
345,439
52-wk High
$80.42
52-wk Low
$41.99

Search Stocks

Sabba, Stephen 

Brief Biography

Dr. Stephen L. Sabba, M.D., serves as an Independent Director of Ligand Pharmaceuticals Inc., August 4, 2008. Dr. Sabba has been a leading Bio/Pharma Analyst and Fund Manager for Knott Partners, L.P., an investment fund company, since November 2006. Previously he was a Partner and Director of Research with Kilkenny Capital Management, a Chicago-based biomedical hedge fund. Prior to that, Dr. Sabba was Director of Research at Sturza’s Medical Research, and previously was a gastroenterologist and internist in private practice at Phelps Memorial Hospital in North Tarrytown, New York. He received his medical degree from the New York University School of Medicine, and completed a residency in internal medicine and a fellowship in gastroenterology at the Veterans Administration Medical Center in New York City. He earned a Bachelor of Science degree with honors at Cornell University. Dr. Sabba has served as a member of the board of the directors for QLT, Inc., a leading Canadian biotech company, since June 2012.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kozarich

--

John Higgins

3,004,910

Nishan de Silva

1,125,130

Matthew Foehr

1,965,460

Charles Berkman

731,761

Jason Aryeh

--
As Of 30 Dec 2013
Search Stocks